A Prospective, Observational Study To Monitor Safety In Patients Who Were Administered With Tigecycline (Tygacil) 50 mg By Intravenous Injection (An Observational Study for Safety - Monitored Release).

Trial Profile

A Prospective, Observational Study To Monitor Safety In Patients Who Were Administered With Tigecycline (Tygacil) 50 mg By Intravenous Injection (An Observational Study for Safety - Monitored Release).

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2011

At a glance

  • Drugs Tigecycline (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions
  • Sponsors Pfizer; Wyeth
  • Most Recent Events

    • 10 Nov 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 10 Nov 2010 Planned number of patients changed from 500 to 621 as reported by ClinicalTrials.gov.
    • 10 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top